The TITRATE-HF registry will provide real-world data on the implementation, sequencing, and prognostic impact of guideline-directed medical therapy in heart failure patients.
TITRATE-HF is a real-world multicentre longitudinal registry that will provide unique information on contemporary GDMT implementation, sequencing strategies (order and speed), and prognosis in de novo, worsening, and chronic HF patients.
Clephas et al. (Fri,) studied this question.